This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2020 Aug 3;8(8):CD001024.

doi: 10.1002/14651858.CD001024.pub3.

Tamoxifen for hepatocellular carcinoma

Anna K Nowak¹, Michael Findlay², Gordana Culjak³, Martin R Stockler⁴

Affiliations

Affiliations

¹ Department of Medical Oncology, Sir Charles Gairdiner Hospital and University of Western Australia, Perth, Australia.
² Director, Cancer Trials New Zealand, Faculty of Medical & Health Sciences, Auckland, New Zealand.
³ Sydney Medical School, Sydney, Australia.
⁴ NHMRC Clinical Trials Centre and Sydney Cancer Centre, The University of Sydney, Camperdown, Australia.

PMID: 32748416
PMCID: PMC10775828
DOI: 10.1002/14651858.CD001024.pub3

Review

Tamoxifen for hepatocellular carcinoma

Anna K Nowak et al. Cochrane Database Syst Rev. 2020.

. 2020 Aug 3;8(8):CD001024.

doi: 10.1002/14651858.CD001024.pub3.

Authors

Anna K Nowak¹, Michael Findlay², Gordana Culjak³, Martin R Stockler⁴

Affiliations

¹ Department of Medical Oncology, Sir Charles Gairdiner Hospital and University of Western Australia, Perth, Australia.
² Director, Cancer Trials New Zealand, Faculty of Medical & Health Sciences, Auckland, New Zealand.
³ Sydney Medical School, Sydney, Australia.
⁴ NHMRC Clinical Trials Centre and Sydney Cancer Centre, The University of Sydney, Camperdown, Australia.

PMID: 32748416
PMCID: PMC10775828
DOI: 10.1002/14651858.CD001024.pub3

Abstract

The review is withdrawn as it has not been updated since its last search for trials in 2004.

Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

PubMed Disclaimer

Update of

Tamoxifen for hepatocellular carcinoma.
Nowak A, Findlay M, Culjak G, Stockler M. Nowak A, et al. Cochrane Database Syst Rev. 2004;(3):CD001024. doi: 10.1002/14651858.CD001024.pub2. Cochrane Database Syst Rev. 2004. Update in: Cochrane Database Syst Rev. 2020 Aug 3;8:CD001024. doi: 10.1002/14651858.CD001024.pub3. PMID: 15266436 Updated.

Publication types

Actions
Actions

LinkOut - more resources

Full Text Sources
Other Literature Sources
- The Lens - Patent Citations Database